SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): July 2, 2003
Commission File Number: 1-18592
Merit Medical Systems, Inc.
------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Utah 87-0447695
------------------------------- ---------------------
(State or other jurisdiction of (IRS Employer
incorporation or organization) Identification No.)
1600 W. Merit Parkway
South Jordan, Utah 84095-2415
---------------------------------------- ---------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's Telephone Number, Including Area Code:
(801) 253-1600
N/A
(Former name, former address, and formal fiscal year, if changed
since last report)
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits
99.1 Press release issued July 2, 2003
ITEM 9. REGULATION FD DISCLOSURE
In accordance with Securities and Exchange Commission Release No.
33-8216, the following information, which is intended to be furnished under Item
12, "Results of Operations and Financial Condition," is being furnished under
this Item 9, "Regulation FD Disclosure."
On July 2, 2003, Merit Medical Systems, Inc. issued the following press
release:
MERIT MEDICAL SYSTEMS, INC. SAYS SECOND QUARTER 2003
EARNINGS PER SHARE WILL EXCEED CONSENSUS ESTIMATES
SOUTH JORDAN, UTAH---Merit Medical Systems, Inc. (NASDAQ:NMS: MMSI),
announced that its earnings per share for the second quarter ended June 30, 2003
will exceed the average analyst consensus estimates of $0.225. Sales for the
second quarter of 2003 were approximately $34.5 million, a 20% increase over
sales for second quarter of 2002 of $28.8 million.
Merit's financial results will be released on Wednesday, July 23, 2003,
following the close of the stock market. The earnings conference call will be
held at 3:00 p.m. MDT, and the telephone number is 800-218-8862 for domestic
participants and 303-205-0033 for international participants.
ABOUT MERIT
Founded in 1987, Merit Medical Systems is a publicly traded company engaged in
the development, manufacture and distribution of proprietary disposable medical
products used in interventional and diagnostic procedures, particularly in
cardiology and radiology. The Company serves client hospitals worldwide with a
domestic and international sales force totaling approximately 74 individuals.
Merit Medical employs approximately 1,200 individuals worldwide, with
manufacturing facilities in South Jordan and Salt Lake City, Utah; Santa Clara,
California; Angleton, Texas; and Galway, Ireland. For more information about
Merit Medical, visit www.merit.com.
Portions of this document contain "forward-looking statements" within
the meaning of the Private Securities Litigation Reform Act of 1995. All
statements other than statements of historical fact are "forward-looking
statements" for purposes of these provisions, including any projections of
earnings, revenues or other financial items, any statement of the plans and
objectives of management for future operations, any statements concerning
proposed new products or services, any statements regarding future economic
conditions or performance, and any statements of assumptions underlying any of
the foregoing. All forward-looking statements included in this document are made
as of the date hereof and are based on information available to Merit as of such
date. Merit assumes no obligation to update any forward-looking statement. In
some cases, forward-looking statements can be identified by the use of
terminology such as "may," "will," "expects," "plans," "anticipates," "intends,"
"believes," "estimates," "potential," or "continue," or the negative thereof or
other comparable terminology. Although Merit believes that the expectations
reflected in the forward-looking statements contained herein are reasonable,
there can be no assurance that such expectations or any of the forward-looking
statements will prove to be correct, and actual results will differ and may
differ materially from those projected or assumed in the forward-looking
statements. Future financial condition and results of operations, as well as any
forward-looking statements, are subject to inherent risks and uncertainties,
including, but not limited to, market acceptance of Merit's products; product
introductions; potential product recalls or product liability claims; delays in
obtaining regulatory approvals; cost increases; fluctuations in and obsolescence
of inventory; price and product competition; availability of labor, materials,
and transportation; development of new products and techniques that could render
Merit's products obsolete; infringing technology; inability to protect Merit's
proprietary technology; foreign currency fluctuations; changes in health care
markets related to health care reform initiatives; limited product
reimbursement; large portions of revenues derived from a few products and
procedures; inability to successfully manage growth; market price volatility of
the Common Stock; dependencies on key personnel; and other factors referred to
in Merit's press releases and filings with the Securities and Exchange
Commission, including Merit's Annual Report on Form 10-K for the year ended
December 31, 2002. Financial statements are subject to change and are not
intended to be relied upon as predictions of future operating results. All
subsequent forward-looking statements attributable to Merit or persons acting on
its behalf are expressly qualified in their entirety by these cautionary
statements.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: July 2, 2003 MERIT MEDICAL SYSTEMS, INC.
By
----------------------------------------------
Kent W. Stanger
(Chief Financial Officer
Principal Financial and Accounting Officer)
3